Back to Stock Analysis

Cipher$CPH.TO

7 research articles

Cipher ($CPH.TO) has 7 independent research articles on RhinoInvestory, written by 4 independent analysts.

Analysts Covering Cipher

Stephen Frampton (3)Leftfield Investing (2)Planet MicroCap Divergent Capital 7651

Research Articles

Counter Cyclicality, Buying Scarce Assets, Inflation Protection + Cipher Thesis $CPH.TO with Dylan Marrello, @ragingbullcap

By Planet MicroCap • 2024-10-31T15:12:54.516Z

Cipher Reports YE 2023 results; Epuris grows +10% Y/Y; company begins planning for commercialization of Terclara; CFO +49% Y/Y; Cash and Cash Equivalents +39% Y/Y offset by stock buybacks

By Leftfield Investing • 2024-03-14T21:58:22.687Z

Cipher Reports YE 2023 results; Epuris grows +10% Y/Y; company begins planning for commercialization of Terclara; CFO +49% Y/Y; Cash and Cash Equivalents +39% Y/Y offset by stock buybacks

By Leftfield Investing • 2024-03-14T21:58:22.687Z

Initial Thoughts on Cipher's Acquisition of ParaPRO's, "Natroba"

By Divergent Capital 7651 • 2024-08-01T03:20:15.320Z

Cipher Pharma - Potential Multibagger in Toenail Fungus - CPH.TO

By Stephen Frampton • 2024-04-06T23:44:25.622Z

Moberg & Cipher – The Final Puzzle Pieces - $MOB.ST $CPH.TO

By Stephen Frampton • 2024-04-22T12:55:44.078Z

Pharma Part 4: Cipher Pulls the Trigger $CPH.TO

By Stephen Frampton • 2024-08-07T15:03:43.743Z